Objectives: The aim of this study was to evaluate nutritional status in children who underwent hematopoietic stem cell transplant compared with a healthy control group. A secondary aim was to utilize midupper arm circumference as a measure of nutritional status in these groups of children. Materials and Methods: Our study group included 40 children (18 girls, 22 boys) with mean age of 9.2 ± 4.6 years (range, 2-17 y) who underwent hematopoietic stem cell transplant. Our control group consisted of 20 healthy children (9 girls, 11 boys). The children were evaluated at admission to the hospital and followed regularly 3, 6, 9, and 12 months after discharge from the hospital. Results: In the study group, 27 of 40 patients (67.5%) received nutritional support during hematopoietic stem cell transplant, with 15 patients (56%) receiving enteral nutrition, 6 (22%) receiving total parenteral nutrition, and 6 (22%) receiving enteral and total parenteral nutrition. Chronic malnutrition rate in the study group was 47.5% on admission to the hospital, with the control group having a rate of 20%. One year after transplant, the rate decreased to 20% in the study group and 5% in the control group. The mid-upper arm circumference was lower in children in the study group versus the control group at the beginning of the study (P < .05). However, there were no significant differences in mid-upper arm circumference measurements between groups at follow-up examinations (P > .05). During follow-up, all anthropometric measurements increased significantly in both groups.
Introduction
Hematopoietic stem cell transplant (HSCT) is a complex procedure consisting of administration of highdose chemotherapy, immunosuppressive the rapy, and/or radiotherapy, followed by intravenous infusion of hematopoietic stem cells to reestablish marrow function in children with hematologic diseases, solid tumors, and autoimmune disorders. 1 Malnutrition is a common problem in children with acute myeloid leukemia and solid tumors who undergo HSCT. The prevalence of malnutrition is between 6% and 50% in these patient groups. 2 Nutrition is a supportive care modality that has been associated with improved tolerance to chemo therapy, improved survival, increased quality of life, and decreased risk of infection in children receiving chemotherapy. 3 The aim of this study was to evaluate nutritional status prospectively in a group of children undergoing HSCT compared with a group of healthy controls. A secondary aim of this study was to utilize mid-upper arm circumference (MUAC) as a measure of nutritional status in these groups of children.
Materials and Methods
The study was approved by the Ethical Review Committee of our Institute. All of the protocols conformed to the ethical guidelines of the 1975 Helsinki Declaration. Written informed consent was obtained from all patients and their guardians.
Design
Our study included 40 children ranging in age from 2 to 17 years (mean of 9.2 ± 4.6 y) admitted to the Bone Marrow Transplantation Unit of Ankara Children's Hematology and Oncology Hospital who were designated as the study group. Twenty healthy children with age and sex distribution comparable to the study group were included as the control group. The nutritional status of the patients was evaluated by a specialized dietitian initiated from the first day of hospitalization. During the transplant period, enteral, parenteral, and oral nutritional support were provided according to the clinical status and age of the children. The children were evaluated at admission to the hospital and followed regularly 3, 6, 9, and 12 months after discharge from the hospital.
Anthropometric measurements and assessment of nutritional status
Body weight was measured using SC-105 model electronic body scale from Bari-Med. Height was measured using Stadiometer model S100 height rod from Ayrton (Frankfurt, Germany). Weight was recorded to the nearest 0.1 kg and height to the nearest 0.1 cm. Mid-upper arm circumference was measured with flexible tape to the nearest 0.1 cm at the halfway point between the acromion and olecranon process of the right upper arm. 4 Body mass index was calculated using the formula of weight (kg)/height (m 2 ). Weight standard deviation score, height standard deviation score, and body mass index standard deviation score were calculated for each patient. 5 We compared data of children in the study group versus those in the control group. World Health Organization (WHO) criteria were used as reference for children younger than 5 years old, whereas WHO/National Center for Health Statistics (NCHS)/Centers for Disease Control (CDC) criteria were used for children older than 5 years in the evaluation of MUAC. The nutritional status was evaluated based on the height for age and weight for age. Values for height for age and weight for age below -2 standard deviations according to the WHO criteria (2006 and 2007) were accepted as malnutrition. 5
Nutritional support
The nutritional status of patients was first evaluated at hospital admission. Enteral nutrition (EN) with oral or nasogastric route was initiated in patients with malnutrition. During the transplant period, L-glutamine (0.5 mg/kg/d) was routinely given. Total parenteral nutrition (TPN) was initiated if the patients could receive < 50% of the daily recommended intake or could not receive oral diet for more than 5 days or had severe mucositis. Minimal EN (1-2 mL/kg/d) was given to patients who needed to receive TPN for a long time to prevent development of intestinal atrophy.
Food consumption assessment
Daily oral caloric intake of patients was recorded during the hospitalization period by a specialized dietitian. At day 7 after transplant and 1 week before discharge, daily energy intake (calories/d) and protein intake (g/d) were calculated by using BeBiS Nutrition Knowledge System Full 7 version (Pacific Durable Industry and Trade Limited Company, Istanbul, Turkey). 6 The daily recommended intake of energy and protein was calculated based on "Dietary Guidelines for Turkey." 7
Statistical analyses
Statistical analyses were performed with SPSS software (SPSS: An IBM Company, version 17.0, IBM Corporation, Armonk, NY, USA). Numerical data were expressed as means ± standard deviation. For normal distribution variables, we used repeatedmeasures analysis of variance for within-and between-group comparisons over time. Paired t test and independent t test were performed for cases of significant interaction. 8 
Results
The mean age of children (18 female and 22 male) in the study group was 9.2 ± 4.6 years, and the mean age of children (9 female and 11 male) in the control group was 9.0 ± 4.3 years. There were no statistically significant differences between age and sex distribution of children in the study and control groups. The demographic and clinical characteristics of the patients are shown in Table 1 .
The rate of chronic malnutrition in the study group was 47.5% on admission to the hospital, whereas that rate was 20% in the control group. One year after transplant, the rate decreased to 20% in the study group and 5% in the control group.
Body weight, height, and body mass index were not different between children in the study and control groups; however, MUAC measurements of children in study group were lower than those measured in children in the control group at the beginning of the study (< -2 standard deviations; P < .05). On the other hand, no statistically significant difference was observed between MUAC measurements of children in the study and control groups at follow-up examinations (P > .05). During follow-up, all anthropometric measurements increased significantly at 3, 6, 9, and 12 months in both groups (P < .001) ( Table 2) .
The daily energy intake of children hospitalized for HSCT was 1280.5 ± 442.0 kcal/d and protein intake was 32.5 ± 13.6 g/d. Unfortunately, these results were under values of recommended daily allowance.
During the transplant period, 27 patients (67.5%) received nutritional support, with 15 patients (56%) receiving only EN, 6 patients (22%) receiving only TPN, and 6 patients (22%) receiving both EN and TPN (Table 3 ). The patients had reached the normal energy and protein requirements with these nutritional supports until discharge from the hospital.
Discussion
Malnutrition is a major prognostic factor for early outcome in patients undergoing allogeneic HSCT. However, very few studies have examined nutritional assessment and nutritional support in children who undergo HSCT. Cohen and Maurice 7 reported that 20% of children admitted for HSCT were at risk for malnutrition. In another study, as many as 46% of children admitted for HSCT were found to have malnutrition. 8 In our study, 47.5% of children admitted for HSCT had malnutrition. The high frequency of malnutrition was thought to be due to the underlying diseases that lead to need for HSCT ( Table 1) . The underlying disease, chemotherapy regimen, and other treatment are major factors determining the degree of malnutrition. However, the malnutrition rate was found to be 20% in the control group. This might be due to the low socioeconomic status of the patients admitted to our hospital. Turkey Demographic and Health Survey revealed that the rate of stunting was 10% among children who were under 5 years of age. 9 These children may face malnutrition during growth 460
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Abbreviations: ATG, antithymocyte globulin; Bu, busulfan; Cy, cyclophosphamide; GVHD, graft-versus-host disease; HSCT, hematopoietic stem cell transplant; TBI, total body irradiation period if their nutritional status is not followed regularly and treated. Malnutrition is still an important health problem all over the world. For this reason, growth monitoring and evaluation of nutritional status are very important factors to detect children with risk of malnutrition. Measurement of malnutrition based on body mass index is very limited because of the alterations in the body compartments during evaluation. However, body composition can be estimated by arm anthropometry, which provides a good projection of whole-body muscle and fat mass. Although arm anthropometry is not routinely performed, it is used for children who undergo HSCT. 10 In this study, MUAC of study patients was found to be significantly lower than that of our control group at admission to the hospital. After 1 year, MUAC measurements of the study group reached normal levels, and no significant difference was detected between study and control groups. Thus, MUAC is a more sensitive, useful, and safer parameter to detect the risk of malnutrition.
The HSCT itself is a major risk factor for malnutrition. 7 Conditioning regimens can result in nausea, vomiting, decreased appetite, diarrhea, development of mucositis, pain, food aversions, altered taste perceptions, and fatigue, and they also contribute to decreased oral intake among children who undergo HSCT. 11 In our study, patients received 67% of recommended daily allowance for daily energy intake and 72% of recommended daily allowance for daily protein intake at admission to our hospital. Two weeks after HSCT, the energy and protein intake decreased to 46% and 47% but increased to 82% and 88% at discharge from the hospital. Enteral nutrition (total 78%) was the main route of nutritional support in our study. We suggest that EN should be preferred to parenteral nutrition from the first day of admission until discharge from the hospital. Nutritional support was needed for 27 of 40 patients (67.5%) in the study group. Regarding type of support, 21 children (78%) received EN with Abbreviations: MUAC, mid-upper arm circumference; P 1 , P difference at admission to month 3; P 2 , P difference at admission to month 6; P 3 , P difference at admission to month 9; P 4 , P difference at admission to month 12
Results are means ± standard deviation (range) for 40 study patients and 20 control patients. 13 suggest that parenteral nutrition may be preferred to EN, especially for patients who undergo allogeneic HSCT. According to many authors, EN is a safer approach as a transition step from parenteral nutrition to the oral diet in patients with gastrointestinal complications. [14] [15] [16] TPN is potentially associated with significant limitations, including fluid overload, catheter-site infections, subclavian vein thromboses, delay in platelet engraftment, and suppression of normal appetite. 17 In the present study, TPN was initiated if the patient could receive < 50% of the daily recommended intake or could not receive oral diet for more than 5 days or if the patient had severe mucositis. In another pediatric study performed at St. Jude Children's Hospital, 67% of children who underwent HSCT received nutritional support and 86% of these children received total parenteral nutrition. 18 The addition of glutamine to the parenteral nutrition formula or as an oral preparation has been investigated in randomized controlled trials. 13 Glutamine is used as a fuel source for rapidly dividing cells and a precursor for synthesis of nucleic acids in stress periods. Glutamine plays a vital role in inducing cellular protection pathways, modulation of the inflammatory response, and prevention of organ injury after illness and/or injury. 19 During the transplant period, oral L-glutamine (500 mg/kg/d) was routinely initiated and it was added to TPN fluid during parenteral nutrition therapy.
In conclusion, meticulous monitoring of nutritional status and initiating enteral or parenteral nutrition support have improved the success of HSCT and provided a more comfortable process during the transplant period. Furthermore, MUAC is a more sensitive, useful, and safer parameter that can be used to measure nutritional status of children who undergo HSCT. During the early period after HSCT, MUAC can measure risk of malnutrition. To prevent development of malnutrition in these children, we suggest that physicians and/or dietitians take these measurements.
